Isobaric versus hypobaric spinal bupivacaine for total hip arthroplasty in lateral position by Faust, Alexandre Michel & Gamulin, Zdravko
UNIVERSITE DE GENEVE FACULTE DE MEDECINE 
 Section de médecine Clinique 
 Département d’Anesthésiologie, 
 Pharmacologie et Soins intensifs de 
 Chirurgie 
 Service d’Anesthésiologie 
 
Thèse préparée sous la direction du Docteur Zdravko Gamulin, PD 
 
 
 
 
ISOBARIC VERSUS HYPOBARIC SPINAL BUPIVACAINE FOR 
TOTAL HIP ARTHROPLASTY IN LATERAL POSITION 
 
 
 
Thèse 
présentée à la Faculté de Médecine 
de l’Université de Genève 
pour obtenir le grade de Docteur en médecine 
 
 
par 
 
Alexandre Michel FAUST 
 
de 
 
Sierre (VS) 
 
 
 
Thèse n° 10346 
 
 
 
Genève 
 
 
 
 
2003 
CONTENTS 
  
RESUME (français) p.3 
 
ABSTRACT p.9 
 
INTRODUCTION p.10 
 
1. Definition p.10 
 
2. Historical p.10 
 
3. Anatomical considerations p.11 
 3.1 Vertebral column p.11 
 3.2 Spinal ligaments p.11 
 3 3 Spinal meninges p.11 
 3.4 The spinal cord p.12 
 3.5 Segmental distribution of the spinal nerves p.12 
 3.6 Autonomic nervous system p.12 
 3.6.1 Sympathetic nervous system p.13 
 3.6.2 Parasympathetic nervous system p.13 
 3.7 Cerebral spinal fluid p.13 
 
4. Physiological considerations of spinal anesthesia p.14 
 4.1 Nociceptors and peripheral pain mechanisms p.14 
 4.2 Cardiovascular effects of spinal anesthesia p.15 
  
5. Pharmacological considerations p.16 
 5.1 Mechanism of spinal anesthesia p.16 
 5.2 Mechanism of spinal anesthesia p.16 
 5.3 Differential sensory/motor blockade p.17 
 5.4 Factors influencing spinal anesthetic activity p.17 
 5.4.1 The baricity of the anesthetic solution p.18 
 
 
 
 1
6. Clinical consideration p.19 
 6.1 Clinical rational for spinal anesthesia p.19 
 6.2 Spinal anesthesia for surgical operations p.20 
 6.3 Contraindications p.20 
 
7. Background and aim of the study p.20 
 
PATIENTS AND METHOD p.22 
 
RESULTS p.26 
 
DISCUSSION p.28 
 
CONCLUSION p.33 
 
FIGURES p.34 
 
TABLES p.44 
 
BIBLIOGRAPHY p.46 
 2
COMPARAISON DE L’ANESTHESIE RACHIDIENNE ISOBARE OU HYPOBARE 
POUR LA CHIRURGIE DE LA PROTHESE TOTALE DE LA HANCHE EN 
POSITION DE DECUBITUS  LATERAL 
 
RESUME 
 
Le but de cette étude est de comparer les effets anesthésiques et hémodynamiques de 
l’anesthésie rachidienne (AR) en utilisant des solutions d’anesthésiques locaux isobares ou 
hypobares, chez des patients bénéficiant de la mise en place d’une prothèse totale de la 
hanche en décubitus latéral. 
L’anesthésie rachidienne (AR) consiste en l’injection d’un anesthésique local (AL) dans 
l’espace sous arachnoïdien (ou intrathécal) qui, en se mélangeant avec le liquide céphalo-
rachidien (LCR) entraîne un blocage de la conduction des nerfs spinaux.  
Se référant aux descriptions de Koller en 1884 concernant les propriétés anesthésiques 
topiques de la cocaïne, James Corning injecte cette substance dans la région médullaire chez 
un chien, ce qui entraîne une paralysie transitoire des membres postérieurs. En 1899, 
Augustus Bier est le premier à administrer de la cocaïne dans l’espace intrathécal en vue 
d'une chirurgie. Par la suite, l’AR va se répandre rapidement en Europe, aux USA ainsi que 
dans les pays du Tiers Monde en raison de sa simplicité, de son efficacité et de son bas prix. 
Alors que nombreux cliniciens considéraient durant la première moitié du siècle les bases 
scientifiques et techniques de l’AR comme bien établies, un net regain d’intérêt s’est 
manifesté durant les dernières décennies grâce en particulier au développement de méthodes 
d’investigations modernes, comme les études randomisées en double aveugle. 
Le canal spinal s’étend du foramen magnum jusqu’au hiatus sacré, mais l’espace sous-
arachnoïdien se termine au niveau de la 2ème vertèbre sacrée (fig. 1a et 1b). La moelle 
épinière se terminant en général au niveau du bord supérieur de L2, la ponction de l’espace 
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sous-arachnoïdien doit s’effectuer en dessous de L2 afin d’éviter tout traumatisme potentiel 
de la moelle épinière. Avant de pénétrer dans l’espace, l’aiguille de ponction doit traverser 
les ligaments spinaux (supra épineux, inter épineux, ligament jaune) (fig. 2) puis la dure-mère 
et l’arachnoïde qui lui est étroitement accolée (fig. 3). L’espace sous-arachnoïdien s’étend 
entre l’arachnoïde et la pie-mère qui adhère la moelle épinière. Il contient la moelle épinière, 
les racines nerveuses et le LCR. La moelle épinière donne naissance à 31 paires de nerfs 
spinaux, chacun composé d’une racine antérieure motrice et d’une racine postérieure 
sensitive. Ces deux racines se joignent pour former des fibres nerveuses sensitives et 
motrices. Chaque segment spinal pourvoit une région spécifique de la peau (dermatome), de 
muscles (myotome) et d’os (ostéome). Lors de l’AR un bloc moteur affecte le mouvement de 
différents articulations et muscles, le blocage sensitif entraîne une anesthésie cutanée dont la 
distribution est décrite dans la figure 5. L’AR peut également entraîner un blocage étendu des 
nerfs sympathiques et parasympathiques dont l’effet va se manifester principalement sur le 
contrôle de l’hémodynamique (pression artérielle et fréquence cardiaque). 
Le liquide céphalo-rachidien (LCR) est clair et transparent, il entoure le cerveau et la moelle 
épinière dans un compartiment liquide appelé l’espace sous arachnoïdien. Il exerce ainsi un 
rôle protecteur contre les traumatismes et tous mouvements brusques. 
Les nocicepteurs sont des récepteurs spécifiques à la douleur, activés par des stimulations 
intenses pouvant entraîner des lésions tissulaires. Ce sont des terminaisons nerveuses libres 
situées dans la peau ainsi que dans d’autres tissus sensibles à la douleur. Différents stimuli 
activent différents types de récepteurs (stimuli thermiques, mécaniques, chimiques). On 
différencie alors les nocicepteurs à leur modalité. Différentes fibres sensitives transmettent 
les impulsions afférentes en réponse aux stimulations douloureuses vers la corne dorsale de la 
moelle épinière. A partir des cellules de la corne dorsale, le stimulus douloureux est transmis 
vers les centres supérieurs. 
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L’hypotension artérielle est une manifestation physiologique fréquente du bloc spinal. Le 
blocage des fibres nerveuses sympathiques préganglionaires en est la cause principale. Ceci 
entraîne une dilatation des vaisseaux de résistance et de capacitance. Les fibres sympathiques 
qui émergent de T1 à T5 contrôlent la fréquence cardiaque. Un bloc spinal qui implique ces 
fibres va causer une dénervation sympathique centrainant une diminution de la fréquence et 
de la contraction cardiaque se manifestant par une diminution du débit cardiaque. De 
l’étendue du bloc spinal, et donc du bloc sympathique, va dépendre le degré de l’hypotension 
artérielle. Des drogues à action vasoactive et chronotrope positive comme l’Ephédrine et 
l’Atropine peuvent être utilisées prophylactiquement ou lorsque l’hypotension apparaît. 
La conduction de l’impulsion le long de la fibre nerveuse est due au gradient électrique à 
travers la membrane de l’axone. Celle-ci résulte du mouvement des ions, en particulier le 
sodium et le potassium à travers la membrane. Un stimulus adéquat réduit le potentiel 
électrique de la membrane, engendrant une phase de dépolarisation rapide (potentiel d’action) 
par entrée de l’ion sodium dans le milieu intracellulaire à travers des canaux membranaires 
spécifiques. Le flux de potassium de l’intérieur vers l’extérieur de la cellule nerveuse permet 
la repolarisation de la membrane. Les anesthésiques locaux (AL) empêchent la dépolarisation 
de la fibre nerveuse par interaction avec un récepteur spécifique du canal à sodium, inhibant 
ainsi la conductance du sodium et donc la conduction nerveuse. 
Les fibres nerveuses sont classées suivant leurs tailles et leur degré de myélinisation. In vitro, 
des études récentes suggèrent que les gosses fibres myélinisées sont plus sensibles aux AL 
que les petites fibres non myélinisées. La quantité d’AL utilisée pour l’AR est un surdosage 
par rapport aux concentrations requises pour bloquer les différents types de fibres Toutefois, 
le niveau céphalique du bloc sympathique est supérieur de 2-3 segments par rapport au bloc 
sensitif, lui-même plus haut que le niveau du bloc moteur. Ce blocage différentiel de la 
conduction nerveuse s’explique par la baisse de la concentration de l’AL à mesure que l’on 
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s’éloigne en direction céphalique du point d’injection. Pour les fibres myélinisées, au 
minimum trois nœuds de Ranvier consécutifs doivent être bloqués pour empêcher la 
conduction. Les petites fibres B des nerfs sympathiques préganglionaires possèdent de 
courtes distances internodales et sont donc plus sensibles aux AL. Les plus grosses fibres 
nociceptives A Delta ont des distances internodales plus grandes et requièrent des 
concentrations d’AL plus grandes pour être bloquées. Enfin, les plus grandes fibres A-Alpha 
ont les plus grandes distances internodales et sont bloquées seulement lorsque la 
concentration en AL est suffisante pour bloquer trois nœuds successifs. 
Nombreux sont les facteurs qui influencent l’étendue et la qualité du bloc spinal comme l’AL 
lui-même, le dosage, l’addition d’autres drogues (opiacés, vasoconstricteurs). L’un des 
facteurs le plus important est la baricité de la solution de l’AL. 
Les solutions d’AL utilisées pour l’AR sont caractérisées selon leur baricité (hypobare, 
isobare et hyperbare). La baricité est définie comme le rapport entre la densité de la solution 
de l’AL à une température donnée et la densité du LCR à la même température. La densité est 
mesurée en gramme pour 1 mL de la solution étudiée, à une température donnée. 
Théoriquement selon cette définition, une solution d’AL isobare a une baricité de 1, alors que 
les solutions hypobares et hyperbares ont une baricité respectivement inférieure et supérieure 
à 1. Les solutions d’AL utilisées pour la RA sont mélangées avec de l’eau pure, une solution 
salée isotonique ou des dextroses afin de les rendre respectivement hypo, iso ou hyperbares. 
Les propriétés physiques des solutions anisobares peuvent être utilisées avantageusement 
pour l’AR. Ainsi, une solution isobare tend à rester proche de la région du point d’injection 
tandis qu’une solution hypobare aura tendance à « flotter » vers le haut et une solution 
hyperbare à « couler » vers le bas (fig. 7). Il est donc théoriquement possible, en choisissant 
la baricité de la solution et la position du patient de diriger préférentiellement l’AL vers les 
nerfs qui doivent être anesthésiés. Ainsi, il doit être possible d’anesthésier préférentiellement 
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l’hémicorps latéral supérieur avec une solution hypobare, injectée en position de décubitus 
latéral. 
Dans notre institution, la mise en place d’une prothèse totale de la hanche en décubitus latéral 
est fréquemment effectuée sous AR en utilisant 15 à 17,5 mg d’une solution de bupivacaine-
0.5 % isobare. L’utilisation d’une solution hypobare devrait en théorie produire une 
distribution sous arachnoïdienne de l’AL plus sélective vers le côté opéré, offrant ainsi un 
bloc moteur et sensitif plus long et plus profond, ce qui peut être un avantage certain en cas 
de prolongation inattendue du temps chirurgical. 
 
La présente étude englobe 40 patients, âgés entre 40 et 75 ans, ASA I ou II, programmés pour 
bénéficier électivement de la mise en place d’une prothèse totale de la hanche en AR. Avec le 
coté opéré vers le haut, les patients ont été assignés au hasard et en double aveugle à recevoir 
une injection spinale de 3.5 mL de bupivacaine-0.5 % (17,5 mg) mélangée à 1.5 mL de 
solution saline 0.9 % (Groupe isobare) ou 1.5 mL d’eau distillée (Groupe Hypobare).  
Le niveau maximal du bloc sensitif avec son temps d’installation et le degré maximal du bloc 
moteur avec son temps d’installation ont été évalués sur les côtés non dépendants (côtés 
opérés) et dépendants (côtés non opérés) jusqu’à régression du niveau sensitif à L2 et jusqu’à 
récupération complète du bloc moteur. Les changements hémodynamiques (pression 
artérielle et fréquence cardiaque) durant les 45 premières minutes après l’injection spinale et 
le temps entre l’injection spinale et le recours à une antalgie en raison de l’apparition d’une 
douleur supérieure à 3 (sur une échelle de 0 à 10) sur le site opératoire ont également été 
notés. La durée de l’anesthésie était définie comme le temps entre l’injection spinale et la fin 
de la chirurgie. La durée de l’analgésie chirurgicale était définie comme le temps entre 
l’injection spinale et le recours à une antalgie en raison de l’apparition d’une douleur de score 
supérieur à 3 sur une échelle visuelle analogique s’étendant de 0 à 10. 
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 Les caractéristiques démographiques des deux groupes étaient comparables.  
Le niveau maximal médian du bloc sensitif et le niveau maximal du bloc moteur étaient 
comparables entre les côtés opérés et non opérés dans chaque groupe et entre les côtés 
correspondants dans les deux groupes. 
Comparé au groupe isobare, le temps entre l’injection spinale et la régression du bloc sensitif 
à L2 sur le côté opéré était plus long pour le groupe hypobare (287± 51 min vs 242± 36 min, 
p<0.004), ainsi que le temps entre l’injection spinale et le recours à une antalgie (290± 46 
min vs 237± 39 min, p<0.001). Il n’y a pas eu de différence dans la qualité du bloc moteur à 
la fin de la chirurgie. 
Les changements hémodynamiques observés durant les premières 45 min après l’injection 
spinale étaient comparables entre les deux groupes. 
 
En conclusion, pour les patients devant bénéficier d’une prothèse totale de la hanche en 
position de décubitus latéral sous anesthésie rachidienne, 17.5 mg de bupivacaine hypobare 
comparée à une dose identique de bupivacaine isobare, prolonge la régression du bloc sensitif 
à L2 et retarde le recours à une antalgie, sans compromettre l’hémodynamique. Nous pensons 
qu’une augmentation de la durée du bloc sensitif de 45 min accroît la sécurité de l’AR pour 
ce type de procédure chirurgicale.  
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ABSTRACT 
 
Total hip arthroplasty is frequently performed under spinal anesthesia using either isobaric or 
hypobaric anesthetic solution. However, these two solutions have never been compared under  
similar surgical conditions. The present study compares anesthetic and hemodynamic effects 
of isobaric and hypobaric bupivacaine in 40 ASA I-II patients undergoing total hip 
arthroplasty in the lateral decubitus position under spinal anesthesia. With operative side up, 
patients randomly received, in a double blind manner, a spinal injection of 3.5 mL (17.5 mg) 
of plain bupivacaine mixed with either 1.5 mL normal saline (Group Isobaric) or 1.5 mL 
distilled water (Group Hypobaric). Sensory level and degree of motor block were evaluated 
on non-dependent and dependent sides until regression to L2 and total motor recovery. 
Hemodynamic changes during the first 45 min after spinal injection, and the time between 
spinal administration and first analgesic for a pain score above 3 (on a 0 to 10 scale) were 
noted. Demographic characteristics of both groups were comparable. Upper sensory level and 
maximal degree of motor block were comparable between operative and nonoperative sides 
in each group and between corresponding sides in both groups. Compared to the isobaric, 
there was in the hypobaric group a prolonged time to sensory regression to L2 on the 
operative side (287 ± 51 min vs 242 ± 36 min, p<0.004) and a prolonged time to first 
analgesic (290 ± 46 min vs 237 ± 39 min, p<0.001). No difference in quality  of motor block 
was noted at the end of surgery. Hemodynamic changes were comparable. We conclude that 
for total hip arthroplasty in the lateral position, spinal hypobaric bupivacaine appears to be 
superior to isobaric in that it prolongs the sensory block on the operative side and delays the 
use of analgesics after surgery without further compromising hemodynamic. 
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INTRODUCTION 
 
1) Definition 
Spinal anesthesia (SA) is the injection of a local anesthetic (LA) into the subarachnoid (or 
intrathecal) space, mixing with the cerebralspinal fluid (CSF) and creating a conduction 
blockade of the spinal nerves. The resultant nerve block provides surgical anesthesia as far 
cephalad as the upper abdomen. 
 
2) Historical 
Following Koller’s description of the topical anesthetic properties of cocaine in 1884, James 
Corning, a surgeon in New York City, injected cocaine into the region of the spinal cord of a 
dog, which resulted in transient hind limb paralysis. In 1899, Augustus Bier, a German 
surgeon, was the first individual to administer cocaine intrathecally for surgical anesthesia. 
Following these initial reports, SA rapidly gained clinical acceptance in Europe and in the 
USA. It continues to be the most commonly used regional anesthesia in the USA and it is 
widely used in the Third World because it is simple, effective and cheap. 
However, in the 1950s, its use almost stopped completely in the UK following the “Wooley 
and Roe” case in which two patients on the same operating list were permanently paralysed 
after spinal injection. It is now certain that these tragedies were the result of the antiquated 
antiseptic measures employed at the time. 
In the last decade, there has been a considerable revival in the interest in, and use of SA. 
While many regarded the scientific basis of the technique to have been well established in the 
first half of the century, modern methods of investigation, especially the double-blind 
randomised trial, have shown that many of the earlier concepts were flawed (1-4) 
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3) Anatomical considerations 
3.1) Vertebral column 
The spinal canal runs from the foramen magnum to the sacral hiatus, but the subarachnoid 
space usually ends at the level of the second sacral vertebra. The spinal cord usually ends at 
the upper border of the second lumbar vertebra though this can vary between T12 and L3 
(figure 1a,b). So it is safest to enter the subarachnoid space below L2. 
 
3.2) Spinal ligaments 
Adjacent vertebrae are held together posteriorly by short tough ligaments. To insert a needle 
into the spinal canal between to vertebrae in the midline, it must traverse the supraspinous 
and interspinous ligaments before reaching the ligamentum flavum, the last barrier to the 
canal itself (figure 2a,b). 
 
3.3) Spinal meninges 
Within the spinal canal there are three sleeves of connective tissues, the dura mater, the 
arachnoid mater and the pia mater, which cover and protect the spinal cord. They form three 
spaces, the epidural space, the subdural space and the subarachnoid space (figure 3). The 
epidural space is that part of the spinal canal between its outer wall and the dura mater. On 
the inner side of the dura mater is the arachnoid matter, which is closely applied to the dura. 
The potential space between the dura and arachnoid mater is the subdural space. The 
subarachnoid space lies between the arachnoid and the pie mater which is adherent to the 
spinal cord. It contains the spinal cord, the nerve roots and the cerebrospinal fluid (CSF). 
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3.4) The spinal cord 
The spinal cord is continuous with the medulla oblongata of the brain and runs from the 
foramen magnum to the upper border of the second lumber vertebra. (It extends to L3 in 10% 
of adults). The spinal cord gives rise to 31 pairs of spinal nerves each composed of an 
anterior motor root and a posterior sensory root (8 cervical, 12 thoracic, 5 lumbar, 5 sacral 
and 1 coccygeal). These two roots join to form both sensory and motor nerve fibres (figure 
4). Because the spinal cord is shorter than the spine, the lower nerve roots become longer and 
more angulated caudally. The lower lumbar, the sacral and the coccygeal roots form, together 
with filum terminal, the cauda equina below the termination of the cord. It is in this region 
were spinal block are performed as the needle can not damage the spinal cord as the rootlets 
forming the cauda equina can move easily in the CSF. 
 
3.5) Segmental distribution of the spinal nerves 
Each spinal segment supplies a specific region of the skin (dermatome), of muscle 
(myotome) and of the bone (osteome). In spinal anesthesia, motor block affects the 
movement of various joints and muscles. The cutaneous distribution of the spinal nerves is 
shown in figure 5. 
 
3.6) Autonomic nervous system 
Spinal anesthesia can cause a widespread blockade of both sympathetic and parasympathetic 
nerves. This has considerable effect, mainly on the control of the circulation (arterial blood 
pressure and heart rate). 
 
 
 
 12
3.6 1) Sympathetic nervous system 
Efferent impulses from the central nervous system to the blood vessels and organs supplied 
by sympathetic nerves must travel along both pre and postganglionic nerves. The ganglia are 
located in the sympathetic chain, and in the large plexuses within the thorax and the 
abdomen. Preganglionic nerves fibres arise from the lateral column of the grey mater of the 
spinal cord and live it through the ventral nerve roots from T1 to L2. The preganglionic nerve 
fibres, which are lightly myelinated, live the spinal nerve to become the white rami 
communicantes which run to the sympathetic chain. The sympathetic chains run the length of 
the spinal column on the anterolateral aspect of the vertebral bodies. The unmyelinated 
postganglionic fibres arising from ganglia are widely distributed to all the organs receiving a 
sympathetic nerve supply. Many run back to the spinal nerves via the grey rami 
communicante and reach structures within the distribution of those spinal nerves. 
 
3.6 2) Parasympathetic system 
Efferent and afferent nerves of the parasympathetic system run either in the cranial nerves 
(cranial outflow) or in the 2nd, 3rd and 4th sacral nerves (the sacral outflow). Unlike all other 
autonomic nerves, the cranial parasympathetic nerves cannot be affected by spinal blockade 
unless the LA diffuses into the cranium. 
 
3.7) Cerebral spinal fluid (CSF) 
CSF is a clear colourless fluid. Both the brain and the spinal cord are enclosed in a fluid 
compartment, namely the subarachnoid space. This serves as protection against trauma due to 
sudden movement. It also supports the brain and cord and maintains a uniform pressure upon 
them. The major portion of the CSF is produced from blood in the choroid plexuses in the 
four ventricules of the brain and is absorbed back into the blood by the arachnoid 
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granulations found in the superior sagittal and transverse venous sinus. The two lateral 
ventricules communicate with the third one through the interventricular foramina. Connecting 
the third and fourth ventricule is the cerebral aqueduct of Sylvius. From the fourth ventricule, 
CSF reaches the cranial subarachnoid space and rises over the surface of the brain (figure 6). 
Apart from the physical protection provided to the brain, CSF provides a chemically stable 
environment. It probably takes part in nourishing the brain, assists in removing the product of 
neuronal metabolism and is important in the distribution and elimination of drugs injected 
into the CSF. Recently, Schiffer et al. (5) reported the density of the human CSF of 1.000529 
± 0.000107 at 37°C (5). Interestingly, they found a significant difference between women and 
men in CSF density, protein and glucose contents. The impact of mass represented by higher 
levels of glucose and proteins in men’s CSF could explain the higher values of CSF density 
measured in men. In addition, they found a significant correlation between CSF density and 
upper sensory block level after injection of 15 mg spinal plain bupivacaine (considered 
slightly hypobaric in most patients but in clinical practice as isobaric (6)) in patients turned 
supine and kept in horizontal position all along the surgical procedure. Though the exact 
mechanism for this relation remains to be elucidated, it could allows a better understanding of 
the unpredictability of the extend of plain bupivacaine spinal anesthesia.  
 
4) Physiological considerations of spinal anesthesia 
4.1) Nociceptors and peripheral pain mechanisms 
Nociceptors are specific pain receptors activated only by intense, tissue-damaging activity. 
They are free nerve endings located in skin and other pain-sensitive tissues. Mechanical 
stimulation activates mechanical nociceptors. Mechanothermal nociceptors respond to 
noxious mechanical or thermal stimulation. Polymodal nociceptors respond to mechanical, 
thermal or chemical stimuli. Fast A-delta or slow C-fibres conduct afferent impulses in 
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response to painful stimuli to the dorsal horn of the spinal cord, via dorsal spinal nerve roots. 
From the cell of the dorsal horn, the painful stimulus is transmitted to higher centres via 
several tracts of which description is beyond the scope of this introduction. 
 
4.2) Cardiovascular effects of spinal anesthesia 
Arterial hypotension is a common physiological manifestation of a spinal block. The primary 
cause of arterial hypotension during SA is the blockade of preganglionic sympathetic nerve 
fibres. This produces dilatation of resistance and capacitance vessels. Sympathetic fibres 
from T1-T5 control cardiac rate. SA that blocks these fibres causes cardiac sympathetic 
denervation that causes a moderate decrease in heart rate as well as a decrease in cardiac 
contractility with the consequence of a diminution of the cardiac output. The degree of 
hypotension relates to the spread of the local anesthetic within the subarachnoid space and 
the extend of the sympathetic blockade. A low block limited to the lumbar or sacral 
dermatomes causes little or no change in blood pressure. In opposite, high spinal anesthesia 
results in sympathetic blockade of fibres innervating the heart as well as those controlling 
peripheral vascular beds and may produce profound hypotension. Both the incidence and the 
degree of hypotension are reduced by limiting the height of the block and by keeping it below 
the sympathetic supply to the heart. Placement of the patient in a slight head-down position 
(5-10°) also limits the hypotension by improvement of the venous return. Vasoconstrictors 
drugs to increase cardiac output and peripheral resistance can be used prophylactically or 
when hypotension occurs. Ephedrine is the drug of choice. 
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5) Pharmacological considerations 
5.1) Mechanism of action of local anesthetics 
The conduction of impulses along nerve fibre is due to changes in the electrical gradient 
across the nerve membrane. This result from movement of ions, particularly sodium and 
potassium, across the membrane. An adequate stimulus that reduces the membrane potential 
produces a spontaneous rapid phase of depolarization (action potential). Depolarization is due 
to the inward passage of sodium from the extracellular to the intracellular space via specific 
channels in the membrane. The flow of potassium from the interior to the exterior of the    
nervous fibre causes repolarization. Local anesthetic (LA) agents prevent depolarization of 
the nerve membrane by blocking the flow of sodium ions. LA, such as lidocaine apparently 
penetrate the lipoprotein membrane matrix to reach the axoplasm and then enter the sodium 
channel where they interact with a specific receptor to block it and inhibit the sodium 
conductance resulting in the blockade of the conduction. The anesthetic profile of a local 
anesthetic is related to the lipid solubility, the protein binding, the pKa and the intrinsic 
vasodilatator activity. From this parameters depend the potency of LA, the duration and the 
onset of action. 
 
5.2) Mechanism of spinal anesthesia 
Nerve fibres are classified on the basis if size and degree of myelination, which in turn 
determine the conduction velocity. In vitro recent studies suggest that large myelinated fibres 
are more sensitive to LA blockade than smaller unmyelinated fibres. LA injected 
intrathecally bind to a greater extent in spinal nerve roots and the periphery of the spinal cord, 
where the small-diameter fibres are located. Less drug diffuses into the dorsal root ganglion 
and centre of the spinal cord. As a result, sensory anesthesia occurs more rapidly than motor 
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blockade. Ultimately sufficient drug reaches the large myelinated fibres to causes motor 
block. 
 
5.3) Differential sensory/motor blockade 
The amount of LA used for spinal anesthesia is an overdosage in relation to the minimum 
concentration required to block the various nerve fibres types. This is the reason for the 
relatively rapid blockade of sensory, sympathetic and motor blockade during clinical spinal 
anesthesia. In general, the cephalad level of sympathetic blockade is 2-3 segments higher 
than the level of sensory blockade, which, in turn is higher than the level of motor blockade. 
This differential level of nerve blockade may be related to several factors: the anesthetic 
concentration within the CSF declines as the cephalad distance from the site of injection 
increases; in myelinated nerve fibres at least three consecutive nodes of Ranvier must be 
completely blocked to prevent conduction; decremental conduction block occurs when 
greater than three nodes are exposed to subminimal blocking concentration of LA. The small 
B fibres in preganglionic sympathetic nerves possess short internodal distances and are most 
susceptible to conduction block, especially at upper spinal levels where CSF concentration of 
LA are low. The larger A-delta nociceptor fibres have longer internodal distances and require 
a higher LA concentration for blockade. The larger A-alpha fibres have the greatest 
internodal distances and are blocked only when the LA concentration is sufficient to inhibit 
three successive nodes. 
 
5.4) Factors influencing spinal anesthetic activity 
The factors that influence the spread and quality of SA include: the LA drug, the dosage of 
LA, the addition of a vasoconstrictor to the solution, the baricity of the solution, the addition 
of opioids to LA and pregnancy. We will concentrate on the baricity of the AL solution. 
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5.4.1) The baricity of the anesthetic solution 
LA used for SA are characterised according to their baricity (hypobaric, isobaric, or 
hyperbaric). Baricity is the ratio of the density of a LA solution at a specified temperature to 
the density of cerebral spinal fluid at the same temperature. Density is the weight in grams of 
1 mL of a solution at a specified temperature. Specific gravity is the ratio of the density of a 
solution at a specified temperature to the density of water at the same temperature. 
Theoretically and according to these definitions, an isobaric LA solution has a baricity of 1 
while hypobaric and hyperbaric solutions have baricities less than or greater than unity, 
respectively. Clinically, hypobaric intrathecal solutions have been defined as those with a 
density less than tree standard deviations below mean human CSF density (7). Green stated 
that the density of a LA solution must be far enough below the mean density of CSF (1.0003) 
to take into account the small but important normal variation in density of CSF about the 
figure of 1.0003 if the solution is to be hypobaric in all patients, not just in some patients. LA 
solutions with baricities less than 0.9990 are predictably hypobaric in all patients (6). Using 
more accurate and precise techniques in the measurements of the density of human CSF, 
Richardson and Wissler (8) determined values for the density of the CSF with ranges much 
narrower than previously reported, defining limit of hypobaricity of intrathecal solutions 
greater than previously proposed (between 1.00016 and 1.00037 g/mL according to the 
variations of CSF density in different subgroup of patients). It is important to note that 
density varies inversely with temperature: therefore, a LA which has the same density as CSF 
at 37°C is more dense (hyperbaric) at room temperature (the temperature at which LA are 
usually injected) than CSF at 37°C. However, the clinically important density of a LA 
solution is that which is measured at 37°C because, during SA, LA solutions rapidly 
equilibrate with the temperature of CSF. 
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LA solutions used for SA are formulated with water, normal saline or dextrose to make them 
hypobaric, isobaric or hyperbaric respectively. 
The significance of baricity lies in the fact that isobaric solutions tend to remain in the area 
where they are injected into the CSF, while hypobaric solutions “float” upwards and 
hyperbaric solutions ”sink” (figure 7). Therefore, it is possible, by selecting the appropriate 
baricity and patient position to “direct” the LA to nerves that need to be anesthetized. For 
example, it is possible to anesthetize the sacral nerves by injecting a hyperbaric solution with 
the patient in the upright position or a hypobaric solution with the patient in the prone jack-
knife position (figure 8). Similarly it should be possible to anesthetize preferentially the 
hemilateral upper part of the body with a hypobaric solution injected in lateral decubitus 
position (1-4). 
 
6) Clinical considerations 
6.1) Clinical rational for spinal anesthesia 
Regional anesthesia such as SA has been shown to of benefit in several areas: 
The metabolic stress response to surgery and anesthesia is much more effectively reduced by 
SA than by general anesthesia (9, 10). Many studies (especially in elective hip surgery) have 
shown a reduction in blood loss of 20-30% in-patients receiving spinal anesthesia versus 
general anesthesia (11). Several studies demonstrated that regional techniques decrease the 
incidence of venous thromboembolic complications by as much as 50%, especially in lower 
extremity procedures (12). Data regarding pulmonary complication are mixed; however, 
pulmonary compromise appears to be less in peripheral procedure performed under regional 
anesthesia. Other area of benefit include avoidance of endotracheal intubation in patients with 
a difficult airway or reactive airway disease and decreased risk of gastric aspiration. 
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6.2) Spinal anesthesia for surgical operations 
Spinal anesthesia produces intense blockade of those spinal nerves, and the spinal cord, 
which are exposed to the injected LA. Somatic pain and motor function are abolished in the 
blocked segments. Visceral pain is also prevented if the appropriate afferent nerves are 
blocked. SA is more suited to surgery below the ombilicus and in this situation the patient 
may remain awake. Surgery above the ombilicus using SA is less appropriate and would 
necessitate a general anesthetic in addition, in order to abolish unpleasant sensations from 
visceral manipulation resulting from afferent impulses transmitted by the vagus nerves. 
 
6.3 Contraindications 
Contraindications include hypovolaemic shock, septiceamia or bacteraemia, pre-existing 
neurological disease, increased intacranial pressure and heamorrhagic diathesis (1-4). 
 
7) Background and aim of the study 
In our institution total hip arthroplasty (THA) in the lateral position is frequently performed 
using single-shot spinal anesthesia with 15 to 17,5 mg of plain bupivacaine 0.5% which 
provides a surgical anesthesia for 3-4 hours. In this particular position, with the non-
dependent (or operative) side up during the spinal injection and all along the surgery, 
hypobaric bupivacaine by “floating” upwards to the hemilateral upper part of the body could 
in theory provide a more selective subarachnoid distribution of local anesthetic on the 
operative side. This can result in a more profound sensory and motor block of longer duration 
in favor of the operative side which could be advantageous in the case of an unexpectedly 
prolonged surgery, since the induction of general anesthesia in the lateral position is not only 
uneasy to perform but presents an increased risk for the patient. Besides, a more selective or 
unilateral block on the operative side should diminished the extend of the blockade of the 
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preganglionic sympathetic fibres and then diminished the degree of systemic arterial 
hypotension often observed after spinal anesthesia. Consequently, the use of hypobaric 
bupivacaine should theoretically increase the reliability of spinal anesthesia for this type of 
surgical procedure. 
 
The use of hypobaric local anesthetic has already been reported for single-shot injection (13, 
14) and continuous spinal anesthesia (15, 16). However, possible advantages of hypobaric 
over isobaric solutions have not been tested in these specific surgical conditions. The aim of 
the present study is to compare the anesthetic and hemodynamic effects of isobaric (plain 
bupivacaine mixed with normal saline) and hypobaric bupivacaine (plain bupivacaine mixed 
with distilled water) solutions for THA performed with patients in the lateral decubitus 
position. 
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PATIENTS AND METHOD 
 
After approval from the Ethics Committee of our institution and written informed consent, 40 
orthopedic patients, between 40 and 75 years old, ASA physical status I or II, scheduled to 
undergo elective THA under single-shot spinal anesthesia were enrolled in the study. 
Exclusion criteria were coagulation disorders, local infection and obvious spinal postural 
abnormalities (cyphosis) as well as inability to comprehend basic aspect of the study. 
 
Preoperative medication consisted of morphine 0.1 mg/kg SC administered one hour before 
arrival in the operating room, in order to ameliorate discomfort of dependent shoulder during 
prolonged lateral decubitus position. Standard noninvasive monitoring consisted in a 
continuous electrocardiogram, peripheral pulse oxymetery, and automatic noninvasive blood 
pressure measurement on the non-dependent arm. More invasive monitoring (i.e. central 
venous pressure invasive arterial pressure or an indwelling urinary catheter) was used only if 
required by the patient’s clinical conditions. After placement of a peripheral intavenous (IV) 
catheter on dependent forearm, preanesthetic hydration consisted of 10 ml/kg of a crystalloid 
solution. During the first hour after spinal injection 5 ml/kg of the same solution were further 
infused. Thereafter fluids were given on the basis of changes in arterial pressure and 
estimated blood loss, replaced with a crystalloid solution on a 3:1 mL basis. When available, 
autologous blood was given if hematocrit dropped under 30% and homologous blood was 
only administered if hematocrit dropped under 26%. 
 
Using a sealed envelope system the patients were randomly assigned to receive either 
hypobaric or isobaric bupivacaine solutions, which were prepared as follow : 
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Isobaric bupivacaine : 3.5 mL (17.5 mg) of plain bupivacaine 0.5% (5 mL vial Carbostesine® 
0.5%, Astra Zeneca, Grafenau, Zug, Switzerland) diluted with normal saline to a total of 5 
ml; measured density at 37 °C was 0.999406 g/mL. 
Hypobaric bupivacaine : 3.5 mL (17.5 mg) of plain bupivacaine 0.5% diluted with distilled 
water, to a total of 5 mL; measured density at 37 °C was 0.997302 g/mL. 
According to the randomization an anesthesiologist not participating in patient’s care or data 
collection prepared 10 mL of distilled water or normal saline. The anesthesiologist in charge 
of the patient withdrew 3.5 mL of plain bupivacaine 0.5% from a 5 mL vial and added 1.5 
mL of the prepared. The density measurements of study solutions were performed using an 
Anton Paar densitometer (DMA 4500, Anton Paar GmbH, Graz, Austria). For each solution 
three measurements were performed and mean value considered. 
 
With the operating table horizontal, the patients were placed in the lateral decubitus position 
with the operated hip up. Lumbar puncture was performed at the L2-L3 interspace with a 25-
Gauge Whitacre needle. After observing a free cerebrospinal fluid (CSF) reflux, the needle 
aperture was oriented upwards and 5 mL of the study solution injected at the rate of 
approximately 0.5 mL/s. The patients remained in the lateral position until the end of surgery, 
at which time they were turned supine. 
 
The following variables were measured throughout the study : 
Evolution of upper sensory block level on non-dependent (operated) and dependent sides. A 
pinprink test (24 gauge needle) was performed on the midthoracic line every 5 min during the 
first 45 min after spinal injection, and then every 15 min until sensory regression to L2 (level 
of the surgical incision). Maximal upper sensory block level, its onset time and time to 
regression to L2 on both sides were recorded. 
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Evolution of degree of motor block using a modified Bromage scale (17) ranging from 0 to 4 
(0 = able to move hip, knee, ankle and toes; 1 = unable to move hip, able to move knee, ankle 
and toes; 2 = unable to move hip and knee, able to move ankle and toes; 3 = unable to move 
hip, knee, ankle, able to move toes; 4 = unable to move hip, knee, ankle and toes) on both 
limbs, every 5 min during the first 45 min after spinal injection. In order not to interfere with 
the surgical procedures, the degree of motor block was not determined during the operation. 
At the end of surgery, degree of motor block was determined again for both limbs and tested 
every 15 min until total motor recovery. Maximal degree of motor block, its onset time, and 
time to total motor recovery of both limbs were recorded. 
Mean arterial pressure (MAP) and heart rate (HR) were recorded every 2.5 min during the 
first 45 min after spinal injection, every 5 min during surgery and every 15 min in the 
recovery room until the end of the study (defined as sensory regression to L2 on both sides 
and/or total motor recovery of both limbs). Maximal decrease in MAP and HR from baseline 
value (determined with patients in the lateral decubitus position just before spinal injection) 
were recorded for the first 45 min after spinal injection. Ephedrine 5-10 mg IV was given if 
MAP decreased by more than 20% from baseline value or if systolic arterial pressure dropped 
below 90 mmHg. Atropine 0.5 mg IV was given if HR decreased less than 45 beats/min. 
Duration of anesthesia was defined as time between spinal injection and the end of the 
surgery. 
Duration of surgical analgesia was defined as the time between spinal injection and the first 
analgesic requirement for a pain score at the operated site above 3 on visual analog scale 
ranging from 0 to 10. 
 
All variables above were determined during anesthesia by the anesthesiologist in charge of 
the patient, and in the recovery room by nurses in charge who were trained to report 
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accurately these variables. Discomfort related to the lateral position during surgery was 
treated with fentanyl 1mcg/kg IV (maximum 2 doses) and anxiety with midazolam 1 mg IV. 
 
Statistical analysis 
Prospective power tests defined the sample size using sensory block level regression time to 
L2 of 157 ± 37 min using 3 mL of plain bupivacaine 0.5%. (18). The sample size was 
computed to detect a 25% difference in favour of the hypobaric group i.e., a longer duration 
of block with a power of 80% and a two-tailed significance level of 5% (β = 0.2; α = 0.05). A 
minimal sample of 14 patients for each group met these criteria. This study enrolled 20 
patients per group. Results are expressed as mean ± SD or median (ranges) for discrete 
variables. Comparisons between groups or between both sides in the same group were 
performed using the Student t test for unpaired or paired data, the Mann-Whitney U test and 
the chi-square test as required. A P value < 0.05 was considered statistically significant. 
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RESULTS 
 
Twenty patients were allocated to each group. One isobaric spinal anesthesia failed. This 
patient was not considered for further analysis. Patient’s demographic and preanesthetic 
hemodynamic data were comparable between the two study groups (table 1). 
 
Median upper sensory levels of both non-dependent (operated) and dependent sides in both 
groups along with onset times are illustrated in figure 9. There was no difference between 
corresponding sides in the two groups or between operated and non-operated sides in the 
same group. 
 
Maximal degree of motor block achieved and onset times are presented in table 2 and are also 
comparable between the two groups and in the same group between both sides. 
 
Duration of anesthesia defined as the time between the spinal injection and the end of the 
surgery was comparable between the two groups, 170 ± 25 min for isobaric and 168 ± 23 min 
for hypobaric. 
 
Sensory regression times to L2 are presented in table 3. When comparing non-dependent and 
dependent sides, patients in both groups show significantly prolonged sensory regression to 
L2 on non-dependent (or operated) side. When comparing both groups (figure 10), regression 
to L2 on the non-dependent side was significantly prolonged in the hypobaric group (287 ± 
51 min vs 242 ± 36 min, p < 0.004); likewise, time to first analgesic requirement was 
significantly longer in the hypobaric group (290 ± 46 min vs 237 ± 39 min, p < 0.001). 
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Since the degree of motor block was not tested during surgery and since at the end of surgery 
complete motor recovery of one or both limbs were observed in some patients, only relevant 
data are available after surgery was completed in all patients, i.e. 225 min after spinal 
injection. At this time in the hypobaric group, 5 patients had a complete motor recovery on 
the non-dependent side compared to 15 on the dependent side (p< 0.0001). In the isobaric 
group, the data (8 vs 11) were not statistically different between the two sides (table 3). In 
addition, contrary to the sensory block (figure 10), there were not statistical difference when 
corresponding sides between the two study groups were compared. 
Hemodynamic changes, observed during the first 45 min after spinal injection, were 
comparable between the two groups. Maximal decrease MAP was 32 ± 13% vs 31 ± 16% and 
for HR 14 ± 11% vs 14 ± 10% for isobaric and hypobaric group respectively (NS) (table 4). 
Ten patients in the isobaric and nine in the hypobaric group received ephedrine; one patient 
in the isobaric group received atropine. 
 
Finally, two patients in the isobaric group received fentanyl for discomfort and 4 received 
midazolam for anxiety. In the hypobaric group three patients received fentanyl and 5 
midazolam. 
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DISCUSSION 
 
The results of the present study demonstrate an advantage of hypobaric over isobaric spinal 
anesthesia in patients undergoing THA in the lateral decubitus position. Although both 
solutions provide satisfactory analgesia overcoming the main surgical duration, the benefit of 
hypobaric bupivacaine is evidenced by a significantly delayed sensory regression to L2 on 
the non-dependent side, thus postponing the need for first analgesic. 
 
Sensory regression to L2 on the non-dependent side lasted 45 min longer in the hypobaric 
group compared to the isobaric group and we believe that this difference is clinically 
relevant, particularly in the context of single-shot spinal anesthesia performed in patients 
undergoing surgery in the lateral position. Because surgical time can sometimes be longer 
than expected and exceed anesthesia time, heavy sedation or even induction of general 
anesthesia can be required, which is often hazardous in the lateral position. 
 
Although described as a possible anesthetic technique (6) there are only a few studies 
reporting the use of hypobaric spinal anesthesia (13-16, 19). Before the present study two 
other reports compared hypobaric and isobaric bupivacaine. Van Gessel et al.(20) reported 
during continuous spinal anesthesia for hip surgery fewer failures with isobaric vs hypobaric 
bupivacaine. However both injection of local anesthetic and surgery were performed with 
patients . Kuusniemi et al. (21) tested small doses (6 mg) of hypobaric and plain bupivacaine 
in the lateral position for knee arthroscopy; twenty min after spinal injection the patients were 
turned supine for surgery. A differential spread for both sensory levels and motor block 
between non-dependent and dependent sides was demonstrated for each solutions. However 
no difference was found between the two solutions, when comparing same sides. 
 28
To our knowledge, the present study is the first comparing isobaric and hypobaric 
bupivacaine in patients undergoing surgery in the lateral position. During progression of 
spinal anesthesia both solutions demonstrate qualities of isobaricity (no difference in upper 
sensory level and maximal degree of motor block between non-dependent and dependent 
sides.) The results of other studies investigating subarachnoid distribution of hypobaric local 
anesthetic in lateral position suggest a dose-related-effect in favor of non-dependent side. As 
previously said, Kuusniemi et al. (21) reported a differential sensory and motor blocks with 
hypobaric solution (6 mg bupivacaine in 3.4 mL). Van Gessel et al. (16) observed a 
differential spread only for motor block when using hypobaric solutions of tetracaine or 
bupivacaine (7.5 mg in 3 mL). Atchison et al. (13) studying the effects of speed of injection 
documented a differential sensory spread between non-dependent and dependent sides with 
10 mg of hypobaric tetracaine in 5 mL when injected over 250 sec with an electrically driven 
syringe pump and through a Whitacre needle with the aperture oriented upward. When the 
same solution is injected rapidly over 10 sec, which approximates usual clinical spinal 
injection speeds, no differential sensory block was found. Using an identical methodology 
Horlocker et al.(14) on the other hand did not show any difference in sensory levels between 
non-dependent and dependent sides in either slow or fast injection groups, using 15 mg of 
hypobaric bupivacaine in 5 ml. Consequently the appearance of a differential block seems to 
be favored by using low dose of hypobaric solution injected in a very slowly. 
 
In our study, the absence of early clinical signs of preferential distribution in favor of the 
non-dependent side in the hypobaric group can be explained essentially by the following 
mechanism. Unlike to hyperbaric solutions (22), there is a relatively small difference in 
density between the hypobaric bupivacaine solution used in the present study (0.997302 
g/mL) and CSF using measurements previously made (5) in our institution (1.000529 ± 
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0.000107 g/mL). This slight difference associated with an elevated dose (17.5 mg) and 
volume (5ml) of hypobaric bupivacaine, moreover injected rapidly over 10 sec favorised an 
initial bilateral subarachnoid distribution. Thus, despite injecting the anesthetic solution 
through a directional Whitacre needle, there was no early evidence of a preferential spread. 
 
However, qualities of hypobaricity evidently appear during regression of spinal anesthesia in 
both groups, but is clinically more relevant in the hypobaric group: 
The regression time to L2 between non-dependent and dependent sides is significantly 
different in the two groups; 
Unlike to the isobaric group, significantly less patients receiving hypobaric bupivacaine show 
a complete motor block recovery on the  non-dependent compared to the dependent side 
(table 3). 
The appearance of this delayed asymmetrical block can be attributed to the differences in 
densities between anesthetic solutions and CSF, associated with prolonged lateral position of 
about 3 hours in the present study. It has also been shown that part of a local anesthetic 
injected intrathecally remains free in CSF at least 60 min, since one hour after administration, 
variations in upper sensory level were found when changing patient position (23, 24). We 
speculate that in the present study 3 hours of lateral decubitus allows more neural fixation on 
the non-dependent roots of hypobaric than isobaric bupivacaine. These arguments could 
explain the more pronounced differential spread of hypobaric over isobaric bupivacaine 
observed during regression of the spinal anesthesia. 
 
In the present study, some degree of differential block is documented for isobaric 
bupivacaine (table 3). Similar findings are reported by others for patients receiving plain 
bupivacaine and tested in the lateral position (21, 25), questioning if plain bupivacaine is 
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isobaric or hypobaric (25). Greene (6) stated that the limit between hypobaric and isobaric 
local anesthetic solutions is a baricity of 0.9990 which is calculated by dividing density of 
local anesthetic with that of CSF. In 1954, Davis and King (7) stated that this limit is a 
density of local anesthetic lower than 3 standard deviations below mean human CSF density. 
Using more precise techniques of measurement of CSF density, Richardson and Wisler (8) 
determined upper limits of hypobaricity as density of local anesthetic between 1.00016 to 
1.00037 g/mL according to the variations of CSF density in different subgroup of patients 
and considers mixture plain bupivacaine-morphine with density of 0.99941 as hypobaric (26). 
Recently we reported the density of plain bupivacaine 0.5% of 0.999343 ± 0.000004 g/mL at 
37°C (20). Compared to this value, the density of hypobaric bupivacaine investigated in the 
present study was lower (0.997302 g/ml) and that of the isobaric solution higher (0.999406 
g/mL). Their baricities calculated with density of CSF of 1.000529 g/mL (5) were 0.996774 
and 0.998876 for hypobaric and isobaric solutions respectively. Thus, hypobaric bupivacaine 
appears to be hypobaric according to the definition of Greene, Davis and Richardson, 
whereas isobaric bupivacaine is at the limit between hypobaric and isobaric for Greene but 
remains hypobaric for Davis and Richardson. It should be noted that these different limits of 
baricity are given arbitrarily and that, besides baricity, there are more than 20 demonstrated 
or theoretical factors influencing subarachnoid distribution of local anesthetics (6). 
Nevertheless, it is admitted that plain bupivacaine 0.5% administered at usual volume of 3 
mL in patients placed supine after injection behave clinically as isobaric (6). However, the 
result of the present study suggest that local anesthetic solutions considered as isobaric, with 
a density even higher than that of plain bupivacaine but lower than that of the CSF, can show 
some signs of hypobaricity in patients kept in prolonged lateral position. 
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Hemodynamic changes were comparable between the two studied groups after the fist 45 min 
initial 3.5 mL spinal injection (table 4). Maximal fall in mean arterial pressure of about 30 % 
can be attributed to the high dose of bupivacaine (17.5 mg) used. This dose was given to 
guarantee success of spinal anesthesia but may be associated with a greater degree of 
hemodynamic derangement in both groups. The absence of an early difference in maximal 
MAP decrease between the two groups can be the reflect of the absence of early clinical signs 
of preferential distribution of LA in favor of the non-dependent side in the hypobaric group 
as discussed previously. Nevertheless, as we discussed before, clinical signs of preferential 
block appear during regression of spinal anesthesia in both groups, but are clinically more 
relevant in the hypobaric group. We can speculate that this preferential block could have been 
correlated with a better hemodynamic in favor of the hypobaric group. However this 
hypothesis is difficult to demonstrate since after 45 min of spinal injection and particularly 
during the surgical procedure, many other factors such as surgical psychological stress, blood 
loss, could make the interpretation of systemic hemodynamic data less accurate. 
 
Concerning the possible influence of the site of injection, we assumed in our study that the 
spinal puncture was performed at the L2-L3 level. It has been shown that the clinical 
determination of spinal level puncture was wrong in 50% of cases (27). Accordingly, we can 
speculate that in the current study that some spinal bupivacaine injection were performed at 
one higher or one lower level. We believe that this fact cannot influence our results since the 
same error would have been repeated in both groups and it seems difficult to imagine that a 
difference by one or two segments in site of lumbar puncture can be responsible for the wide 
variation in upper spread of spinal block observed (8 segments for the non-dependent side of 
both groups and 14 and 12 segments for the dependent side of isobaric and hypobaric group 
respectively (fig. 9).  
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CONCLUSION 
 
For patients undergoing THA in lateral position under spinal anesthesia, 17.5 mg of 
hypobaric bupivacaine, compared to identical dose of isobaric bupivacaine, prolongs sensory 
regression to L2 and delays the use of first analgesic, without further compromising systemic 
hemodynamics. We believe that 45 min longer duration of spinal anesthesia is clinically 
relevant and increases the reliability of hypobaric spinal anesthesia for this type of surgical 
procedure.  
 
Further investigations could be performed by adding for example adrenaline in the hypobaric 
solution. This could theoretically increase the duration of the block. Thus it could be possible 
to diminish the dose local anesthetic to obtain an early more selective block and to insure a 
better hemodynamic. 
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Table 1: Patients characteristics and preanesthetic
hemodynamic variables (mean ± SD)
Isobaric Hypobaric
n = 19 n = 20
Age (yr) 63 ± 8 61 ± 10
Weight (kg) 72 ± 12 81 ± 15
Height (cm) 166 ± 8 166 ± 10
ASA status (I/II) 6/13 2/18
Female/Male ratio 11/8 11/9
MAP (mmHg) 103 ± 16 104 ± 13
Heart rate (beats/min) 73 ± 15 76 ± 16
ASA: American Society of Anesthesiology
MAP: Mean arterial pressure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Motor block characteristics
 (median with range in brackets or mean ± SD)
      ISOBARIC (n = 19)      HYPOBARIC (n = 20)
     Non-dependent Dependent      Non-dependent Dependent 
Maximal degree of motor block            4 (4)       4 (3-4)            4 (4)        4 (1-4)
Onset time (min)            16 ± 4       22 ± 9            13 ± 7        16 ± 10
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Table 3: Times of sensory regression to L2 (mean ± SD) and motor block caracteristic at 225 min 
after spinal injection
            ISOBARIC (n = 19)             HYPOBARIC (n = 20)
Non-dependent Dependent Non-dependent Dependent 
Regression to L2 (min) 242 ± 36 * 219 ± 30 287 ± 51** 233 ± 38
Nb of patients with complete motor recovery 8 11 5 ** 15
(0 degree of motor block)
at 225 min
* p < 0.005, ** p < 0.0001 between non-dependent and dependent sides
 
 
 
 
 
 
 
 
 
 
Table 4: Hemodynamic changes observed during the first 45 min 
after initial 3.5 mL spinal injection (mean ± SD)
ISOBARIC HYPOBARIC
n = 19 n = 20
Maximal decrease from 
preanesthethic baseline value in 
   MAP (%) 32 ± 13 31 ± 16
    HR (%) 14 ± 11 14 ± 10
Time to reach maximal decrease in 
    MAP (min) 24 ± 11 21 ± 10
    HR (min) 29 ± 14 27 ± 18
MAP: Mean arterial pressure
HR: Heart rate
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